AI assistant
AGENUS INC — Director's Dealing 2014
Mar 5, 2014
34023_dirs_2014-03-05_eddd9f0e-c0b0-47c6-bc16-c851a57fa8e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2014-03-03
Reporting Person: ARMEN GARO H (Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-03 | Common Stock | J | 3760 | $3.51 | Acquired | 1626662 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 43900 | Indirect |
Footnotes
F1: Represents issuance of stock for payment of 33% of Dr. Armen's base salary for February 2014.
F2: Dr. Armen is trustee and has investement authority for the Garo Armen 2012 2 Year GRAT holding 38,854 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership therein. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership of this pecuniray interest therein.